Colon primary cancer with metastatic
To Order Contact us: lieven@wlsolutions.be
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Colon |
||
T6235090-PM | 5 slides x2 | EUR 736 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Colon |
||
T8235090-PM | 5 slides x2 | EUR 626 |
Ovary primary carcinoma with matched metastatic carcinoma tissue array |
||
OV812 | each | EUR 270 |
Description: Ovary primary carcinoma with matched metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 40 cases/80 cores |
Cancer Antigen CEA Antigen (Human Metastatic Liver of Colon Adenocarcinoma) |
||
VAng-Wyb8646-inquire | inquire | Ask for price |
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver of Colon Adenocarcinoma, 7.8 mg/mL. |
Lung cancer tissue array with matched metastatic lymph node |
||
LC814a | each | EUR 306 |
Description: Lung cancer tissue array with matched metastatic lymph node, 40 cases/80 cores, replacing LC814 |
Breast cancer with matched metastatic carcinoma or breast tissue array |
||
BRM961a | each | EUR 384 |
Description: Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores |
Lung cancer with matched lymph node metastatic carcinoma tissue array |
||
LC817b | each | EUR 258 |
Description: Lung cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC817a |
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue |
||
LC953 | each | EUR 1434 |
Description: Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue, including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952 |
Breast cancer with matched metastatic carcinoma of lymph node tissue array |
||
BR1005b | each | EUR 306 |
Description: Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Lung |
||
D8235152-PM-10 | 2x10 ug | EUR 690 |
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue |
||
CO952a | each | EUR 1434 |
Description: Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores. |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Liver |
||
D8235149-PM-10 | 2x10 ug | EUR 690 |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Breast |
||
D8235086-PM-10 | 2x10 ug | EUR 690 |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Kidney |
||
D8235142-PM-10 | 2x10 ug | EUR 690 |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Rectum |
||
D8235206-PM-10 | 2x10 ug | EUR 690 |
Cervix cancer and normal tissue array with CIN and metastatic carcinoma |
||
CR208 | each | EUR 546 |
Description: Cervix cancer and normal tissue array with CIN and metastatic carcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores |
Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Stomach |
||
D8235248-PM-10 | 2x10 ug | EUR 690 |
Liver metastatic cancer tissue array |
||
MLV801 | each | EUR 354 |
Description: Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores |
Cancer of the cervix paired with metastatic tumors in lymph nodes, 12 cases (1.5mm) |
||
CXM481 | 1 | EUR 300 |
Description: Cervical cancer tissue array containing paired primary (in duplicates) and lymph node metastasis (in duplicates) from the same patients, 48 cores, 12 cases. |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Lung |
||
R8235152-PM-10 | 2x10 ug | EUR 716 |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Liver |
||
R8235149-PM-10 | 2x10 ug | EUR 716 |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Breast |
||
R8235086-PM-10 | 2x10 ug | EUR 716 |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Kidney |
||
R8235142-PM-10 | 2x10 ug | EUR 716 |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Rectum |
||
R8235206-PM-10 | 2x10 ug | EUR 716 |
Metastatic esophageal cancer tissue array |
||
ES806 | each | EUR 306 |
Description: Metastatic esophageal cancer tissue array, 40 cases/80 cores |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Liver |
||
C8235149-PM | 10 reactions x2 | EUR 1102 |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Lung |
||
C8235152-PM | 10 reactions x2 | EUR 1102 |
Matched Pair - Total RNA - Human Primary and Metastatic Tumor Tissue: Stomach |
||
R8235248-PM-10 | 2x10 ug | EUR 716 |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Breast |
||
C8235086-PM | 10 reactions x2 | EUR 1102 |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Kidney |
||
C8235142-PM | 10 reactions x2 | EUR 1102 |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Rectum |
||
C8235206-PM | 10 reactions x2 | EUR 1102 |
Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Stomach |
||
C8235248-PM | 10 reactions x2 | EUR 1102 |
Multiple organ metastatic cancer tissue array |
||
MT2081 | each | EUR 474 |
Description: Multiple organ metastatic cancer tissue array, 19 organ/104 cases/208 cores |
Cancer of the colon paired with metastasis, 48 cases (1.5mm) |
||
COM961 | 1 | EUR 433.2 |
Description: Colon metastatic cancer tissue array, 96 cores including 12 cases of colon cancers with matched adjacent normal tissues, 36 cases of colon cancers paired with lymph node metastasis. |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma |
||
KD951a | each | EUR 1434 |
Description: Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replacing KD951 |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Liver |
||
P8235149-PM | 0.2 mg x2 | EUR 1325 |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Lung |
||
P8235152-PM | 0.2 mg x2 | EUR 1325 |
Cancer Antigen CEA Antigen (Human Metastatic Liver) |
||
VAng-Wyb8645-inquire | inquire | Ask for price |
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL. |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Breast |
||
P8235086-PM | 0.2 mg x2 | EUR 1325 |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Kidney |
||
P8235142-PM | 0.2 mg x2 | EUR 1325 |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Rectum |
||
P8235206-PM | 0.2 mg x2 | EUR 1325 |
Matched Pair - Total Protein - Human Primary Tumor and Metastatic Tumor Tissue (PM): Stomach |
||
P8235248-PM | 0.2 mg x2 | EUR 1325 |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Lung |
||
T6235152-PM | 5 slides x2 | EUR 736 |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL |
||
BNUB3750-100 | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL |
||
BNUB3750-500 | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 1mg/mL |
||
BNUM3750-50 | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Breast |
||
T6235086-PM | 5 slides x2 | EUR 736 |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Kidney |
||
T6235142-PM | 5 slides x2 | EUR 736 |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Liver |
||
T6235149-PM | 5 slides x2 | EUR 736 |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Rectum |
||
T6235206-PM | 5 slides x2 | EUR 1088 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Lung |
||
T8235152-PM | 5 slides x2 | EUR 626 |
Matched Pair - Frozen Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Stomach |
||
T6235248-PM | 5 slides x2 | EUR 736 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Breast |
||
T8235086-PM | 5 slides x2 | EUR 626 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Kidney |
||
T8235142-PM | 5 slides x2 | EUR 626 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Liver |
||
T8235149-PM | 5 slides x2 | EUR 626 |
Matched Pair - Paraffin Tissue Section - Human Primary and Matched Metastatic Tumor (PM): Rectum |
||
T8235206-PM | 5 slides x2 | EUR 626 |
Matched Pair - Paraffin Tissue Sections - Human Primary and Matched Metastatic Tumor (PM): Stomach |
||
T8235248-PM | 5 slides x2 | EUR 626 |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL |
||
BNUB2225-100 | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL |
||
BNUB2225-500 | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL |
||
BNUB2226-100 | 1uL | EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL |
||
BNUB2226-500 | 1uL | EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 1mg/mL |
||
BNUM2225-50 | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 1mg/mL |
||
BNUM2226-50 | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Breast cancer and matched metastatic carcinoma tissue array |
||
BR10010f | each | EUR 354 |
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade,IHC (ER,PR,Her-2,Ki67) markers results, 50 cases/100 cores, replacing BR10010e |
Breast cancer and matched metastatic carcinoma tissue array |
||
BR20837a | each | EUR 546 |
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores, replacing BR20837 |
Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples |
||
ME551 | each | EUR 270 |
Description: Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples, including TNM and clinical stage (reference AJCC th version), 49cases/55 cores (core size 1.5mm) Recent Year Collection |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL |
||
BNC403750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL |
||
BNC403750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL |
||
BNC473750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL |
||
BNC473750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL |
||
BNC043750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL |
||
BNC043750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL |
||
BNC683750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL |
||
BNC683750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL |
||
BNC883750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL |
||
BNC883750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL |
||
BNCB3750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL |
||
BNCB3750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL |
||
BNC943750-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL |
||
BNC943750-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Cancer Antigen CA 19-9 Antigen (Human metastatic liver carcinoma) |
||
VAng-Wyb8635-inquire | inquire | Ask for price |
Description: CA 19-9 (Gastrointestinal Cancer), Antigen Grade, Cancer antigen from Human metastatic liver carcinoma, 2900.0 kIU/mL. |
Metastatic Tumor Tissue Array - 18 cases of metastatic cancers from 4 anatomic sites |
||
Z7020073 | 5 slides | EUR 1125.6 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Metastatic Tumor Tissue Array - 48 cases of metastatic cancers from 8 anatomic sites |
||
Z7020074 | 5 slides | EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL |
||
BNC472225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL |
||
BNC472225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL |
||
BNC472226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL |
||
BNC472226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL |
||
BNC682225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL |
||
BNC682225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL |
||
BNC682226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL |
||
BNC682226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL |
||
BNC942225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL |
||
BNC942225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL |
||
BNC942226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL |
||
BNC942226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PC-3 Human prostate cancer cells derived from metastatic cancer cell line: >1x10^10 frozen exosomes |
||
EXOP-115A-1 | 50 ug | EUR 409 |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL |
||
BNC402225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL |
||
BNC402225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL |
||
BNC402226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL |
||
BNC402226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL |
||
BNC882225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL |
||
BNC882225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL |
||
BNC882226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL |
||
BNC882226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL |
||
BNC042225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL |
||
BNC042225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL |
||
BNC042226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL |
||
BNC042226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL |
||
BNCB2225-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL |
||
BNCB2225-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL |
||
BNCB2226-100 | 1uL | EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL |
||
BNCB2226-500 | 1uL | EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Colon adenocarcinoma and metastatic adenocarcinoma tissue array |
||
CO953a | each | EUR 1434 |
Description: Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953 |
Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores |
||
FMG1001 | row: 10; column: 10; cores: 100; cases: 96 | EUR 258 |
Description: Breast cancer and breast tissue microarray, contaning 44 cases of invasive carcinoma of no special type, 5 medullary carcinoma, 1 neuroendocrine carcinoma, 37 metastatic invasive carcinoma of no special type, 2 metastatic lobular carcinoma, 1 metastatic medullary carcinoma, 3 breast tissue, 7 adjacent normal breast tissue, single core per block |
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 |
||
UBD208a | row: 12; column: 16; cores: 192; cases: 64 | EUR 546 |
Description: Multiple bladder carcinoma with bladder tissue microarray, containing 38 cases of urothelial carcinoma, 6 squamous cell carcinoma, 7 adenocarcinoma, 4 metastatic urothelial carcinoma, 9 bladder tissue, triplicated cores per case |
Metastasis-associated in colon cancer protein 1 |
||
AP84814 | 1mg | EUR 2640 |
Colon cancer with colon tissue array |
||
CO1021a | each | EUR 306 |
Description: Colon cancer with colon tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results,TNM and clinical stage, containing 86 cases of adenocarcinoma, 4 papillary adenocarcinoma, 7 mucinous adenocarcinoma, 2 adenoma, 1 congenital megacolon, 2 colon tissue, 102 cases/102 cores replacing CO1021 |
Colon cancer with colon tissue array |
||
CO1921 | each | EUR 546 |
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores |
Colon cancer with colon tissue array |
||
CO2161b | each | EUR 474 |
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 216 cases/216 cores, replacing CO2161a |
Colon cancer with colon tissue array |
||
CO721 | each | EUR 270 |
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores |
Colon cancer with colon tissue array |
||
CO805 | each | EUR 258 |
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
abx234920-100ug | 100 ug | EUR 610.8 |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx242861 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx104134 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx210666 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx210667 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx132298 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx121640 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx325504 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody |
||
20-abx338434 |
|
|
MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes |
||
EXOP-105A-1 | 50 ug | EUR 409 |
Human Metastasis Associated In Colon Cancer 1 ELISA Kit |
||
IHUMACC1KT | each | EUR 799 |
Description: Human Metastasis Associated In Colon Cancer 1 ELISA Kit |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
4-RPM667Hu01 |
|
|
Description: Recombinant Human Metastasis Associated In Colon Cancer 1 expressed in: E.coli |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
RPU42748-100ug | 100ug | EUR 603.9 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
RPU42748-1mg | 1mg | EUR 2675.4 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
RPU42748-50ug | 50ug | EUR 485.1 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
RPM667Hu01 | 10ug | EUR 196 |
Recombinant Metastasis Associated In Colon Cancer 1 (MACC1) |
||
RPM667Hu02 | 10ug | EUR 198 |
Colon cancer with matched colon tissue array |
||
CO1801a | each | EUR 474 |
Description: Colon cancer with matched colon tissue array, including pathology grade,with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage, containing 90 cases of adenocarcinoma, and 90 cancer adjacent or adjacent normal colon tissue, 90 cases/180 cores, replacing CO1801 |
Colon cancer with matched colon tissue array |
||
CO602a | each | EUR 222 |
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 30 cases/60 cores, replacing CO602 |
Colon cancer with matched colon tissue array |
||
CO703 | each | EUR 198 |
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 35 cases/70 cores,replaced by CO703a |
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (HRP) |
||
20-abx336504 |
|
|
Human Metastasis Associated In Colon Cancer 1 (MACC1) Protein |
||
20-abx068004 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (FITC) |
||
20-abx336505 |
|
|
ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1) |
||
SEM667Hu | 96Т | EUR 770 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) CLIA Kit |
||
20-abx496070 |
|
|
Metastasis Associated In Colon Cancer 1 (MACC1) Antibody (Biotin) |
||
20-abx336506 |
|
|
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
20-abx152254 |
|
|
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
abx251113-96tests | 96 tests | EUR 895.2 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
abx572579-96tests | 96 tests | EUR 801.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
DLR-MACC1-Hu-48T | 48T | EUR 664.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
DLR-MACC1-Hu-96T | 96T | EUR 870 |
Description: A sandwich quantitative ELISA assay kit for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
SEM667Hu-10x96wellstestplate | 10x96-wells test plate | EUR 6227.58 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
SEM667Hu-1x48wellstestplate | 1x48-wells test plate | EUR 618.04 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
SEM667Hu-1x96wellstestplate | 1x96-wells test plate | EUR 831.48 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
SEM667Hu-5x96wellstestplate | 5x96-wells test plate | EUR 3381.66 |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
4-SEM667Hu |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Metastasis Associated In Colon Cancer 1 (MACC1) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKU05926-48T | 48T | EUR 610.82 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKU05926-5x96T | 5x96T | EUR 4144.85 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKU05926-96T | 96T | EUR 872.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKN47037-48T | 48T | EUR 416.29 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKN47037-5x96T | 5x96T | EUR 2824.83 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EKN47037-96T | 96T | EUR 594.7 |
Human Metastasis Associated In Colon Cancer 1 ELISA Kit (MACC1) |
||
RK01812 | 96 Tests | EUR 625.2 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RD-MACC1-Hu-48Tests | 48 Tests | EUR 675.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RD-MACC1-Hu-96Tests | 96 Tests | EUR 939.6 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RDR-MACC1-Hu-48Tests | 48 Tests | EUR 706.8 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RDR-MACC1-Hu-96Tests | 96 Tests | EUR 984 |
Human MACC1(Metastasis Associated In Colon Cancer 1) ELISA Kit |
||
ELK6402-48T | 48T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MACC1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MACC1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MACC1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MACC1 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human MACC1(Metastasis Associated In Colon Cancer 1) ELISA Kit |
||
ELK6402-96T | 96T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MACC1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MACC1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MACC1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MACC1 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit |
||
QY-E02795 | 96T | EUR 433.2 |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RDR-MACC1-Hu-48T | 48T | EUR 518.18 |
Description: serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RDR-MACC1-Hu-96T | 96T | EUR 740.25 |
Description: serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
DL-MACC1-Hu | 96T | EUR 481 |
Description: serum, plasma, tissue homogenates or other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
DLR-MACC1-Hu | 96T | EUR 505 |
Description: serum, plasma, tissue homogenates or other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RD-MACC1-Hu-48T | 48T | EUR 493.5 |
Description: serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
RD-MACC1-Hu-96T | 96T | EUR 705 |
Description: serum, plasma, tissue homogenates and other biological fluids. |
Human Metastasis Associated In Colon Cancer 1 (MACC1) ELISA Kit |
||
EK15325 | 96Т | EUR 768 |
Melanoma Tissue Array - 12 cases of normal epithelium, nevus, and carcinoma of the skin, and 36 cases of primary (26 cases) and metastatic (10 cases) melanomas in duplicates. |
||
Z7020108 | 5 slides | EUR 1657.2 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Colon cancer with cancer adjacent tissue array |
||
T051b | each | EUR 48 |
Description: Colon cancer with cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T051a |
Colon tissue array with colon cancer tissue |
||
BN05014a | each | EUR 222 |
Description: Colon tissue array with colon cancer tissue, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BN05014 |